🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested
The main objective of this trial is to evaluate the effects of a single the...
Status
Completed
Location
Quotient Sciences
Start Date
2024-03-06
Trial ID
NCT06107036
Treatments Being Tested
In this study, researchers want to find whether the study drug BAY1817080 h...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2020-06-18
Trial ID
NCT04423744
Treatments Being Tested
Incidence of visual phenomena, heart rate at rest, safety (with particular ...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT02264015
To evaluate the effect of idalopirdine (120 and 360 mg) on cardiac repolari...
Status
Completed
Location
FR801
Start Date
2015-05
Trial ID
NCT02436486
Treatments Being Tested
The Phase I Thorough QT/QTc (TQT) study will be performed in a single cente...
Status
Completed
Location
Vince and Associates Clinical Research
Start Date
2018-09-25
Trial ID
NCT03613649
Treatments Being Tested
The primary objective of this trial is to assess the effect of BI 409306 on...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-05-09
Trial ID
NCT03934203
Treatments Being Tested
This will be a double-blind, 4-period, randomized, cross-over study conduct...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01756495
Treatments Being Tested
A randomised, placebo controlled thorough QTc study to evaluate the effect ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-23
Trial ID
NCT01209026